IP Library Granted Patent US 7,132,110
Granted Patent B2
US 7,132,110 · App. 10/195,671 · Granted Nov 7, 2006

Tissue repair compositions and methods for their manufacture and use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,132,110
App. No.
10/195,671
Granted
Nov 7, 2006
Kind
B2
Abstract

An osteogenic composition is prepared by a process including the steps of subjecting demineralized bone to an extraction medium to produce an insoluble extraction product and a soluble extraction product, separating the insoluble extraction product and the soluble extraction product, drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product, and combining the dried soluble extraction product of step c) with demineralized bone particles. Preferably, the process does not involve heating.

Claims (115)

1. An osteogenic composition resulting from a process comprising:

(a) subjecting demineralized bone to an acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature between about 15° C. and 25° C. to produce an insoluble extraction product and a soluble extraction product;

(b) separating the insoluble extraction product and the soluble extraction product;

(c) drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product to produce a dried soluble extraction product; and

(d) combining the dried soluble extraction product of step (c) with demineralized bone particles.

2. The osteogenic composition of claim 1 , wherein the dried soluble extraction product is subsequently hydrated and the composition has the consistency of a gel, paste or putty.

3. The osteogenic composition of claim 1 , wherein the process further comprises the step of (e) combining the dried soluble extraction product with an alcohol and removing the alcohol by drying, and wherein the composition has the consistency of a sponge.

4. The osteogenic composition of claim 1 , wherein step (a) is conducted under vacuum.

5. The composition of claim 1 , wherein the soluble extraction product is osteoinductive.

6. The composition of claim 1 , wherein the extraction medium comprises citric acid, hydrochloric acid, acetic acid, lactic acid or malic acid.

7. The composition of claim 1 , further comprising sterilizing the osteogenic composition.

8. The composition of claim 7 , wherein the sterilizing is conducted by electron beam radiation sterilization.

9. The composition of claim 1 , wherein the drying of step (c) comprises lyophilization.

10. The composition of claim 1 , which further comprises the insoluble extraction product.

11. A method for preparing an osteogenic composition comprising:

(a) subjecting demineralized bone to an acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature between about 15° C. and 25 ° C. to produce an insoluble extraction product and a soluble extraction product;

(b) separating the insoluble extraction product and the soluble extraction product;

(c) drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product to produce a dried soluble extraction product; and

(d) combining the dried soluble extraction product of step (c) with demineralized bone particles.

12. The method of claim 11 , wherein the dried soluble extraction product is subsequently hydrated and the composition has the consistency of a gel, paste or putty.

13. The method of claim 11 , wherein the method further comprises the step of combining the dried soluble extraction product with an alcohol and removing the alcohol by drying, and wherein the composition has the consistency of a sponge.

14. The method of claim 11 , wherein step (a) is conducted under vacuum.

15. The method of claim 11 , wherein the soluble extraction product is osteoinductive.

16. The method of claim 15 , wherein the extraction medium comprises citric acid, hydrochloride acid, acetic acid, lactic acid or malic acid.

17. The method of claim 11 , further comprising sterilizing the osteogenic composition.

18. The method of claim 17 , wherein the sterilization is conducted by electron beam radiation sterilization.

19. The method of claim 11 , wherein the drying of step (c) comprises lyophilization.

20. The method of claim 11 , wherein the composition further comprises the insoluble extraction product.

21. An osteogenic surgical implant comprising a surgical implant coated with the composition of claim 1 .

22. A method of treating a bone defect comprising:

(a) providing a surgical implant;

(b) coating the surgical implant with the composition of claim 1 ; and

(c) implanting the surgical implant at a bone defect site.

23. A composition comprising a separated soluble extraction product derived from demineralized bone contacted with acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature between about 15° C. and 25° C.

24. The composition defined in claim 23 wherein the product further contains proteins endogenous to the demineralized bone.

25. The composition defined in claim 24 further comprising an insoluble extraction product derived from demineralized bone.

26. The composition defined in claim 24 further comprising demineralized bone.

27. The composition defined in claim 26 further comprising an insoluble extraction product from demineralized bone.

28. The composition defined in claim 27 wherein the composition comprises only materials derived from bone.

29. The composition defined in claim 27 wherein the composition consists essentially of the soluble extraction product, the insoluble extraction product and the demineralized bone.

30. The composition defined in claim 23 further comprising at least one component selected from the group consisting of bone morphogenetic proteins, cartilage derived morphogenetic proteins (CDMPs), cortical bone, cancellous bone, bone mineral, osteogenic chemical, osteogenic peptide, osteogenic growth factor, recombinant bone morphogenetic protein, fibronectin, blood-derived protein, thickening material, collagen, insoluble extraction product, calcium phosphate, hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate, calcium sulfate, biological glass, natural polymer, synthetic polymer, poloxamer, and reverse phase medium.

31. The composition defined in claim 30 wherein the component is cancellous bone.

32. The composition defined in claim 30 wherein the component is bone mineral.

33. The composition defined in claim 30 wherein the component is at least one component selected from the group consisting of hydroxyapatite, tricalcium phosphate, biphasic calcium phosphate, and poloxamer.

34. The composition defined in claim 30 wherein the component is poloxamer.

35. The composition defined in claim 33 further comprising demineralized bone.

36. The composition defined in claim 34 further comprising demineralized bone.

37. The composition defined in claim 34 further comprising an insoluble extraction product from demineralized bone.

38. The composition defined in claim 36 further comprising an insoluble extraction product from demineralized bone.

39. A method of making an osteogenic material comprising:

(a) subjecting demineralized bone matrix to an acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature between about 15° C. and 25° C. under conditions to produce an insoluble extraction product and a soluble extraction product; and

(b) separating the insoluble extraction product and the soluble extraction product.

40. The method defined in claim 39 further comprising

(c) treating the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product.

41. The method defined in claim 40 further comprising

(d) combining the treated soluble extraction product of step (c) with demineralized bone.

42. The method defined in claim 41 further comprising

(e) combining the treated combination of step (d) with the insoluble extraction product.

43. The method defined in claim 40 further comprising adding the treated soluble extraction product of step (c) to an alcohol; and removing the alcohol;

wherein the composition has the consistency of a sponge.

44. The method defined in claim 40 further comprising hydrating the treated soluble extraction product of step (c);

wherein the hydrated composition has the consistency of a gel, paste or putty.

45. The method of claim 40 , wherein step (a) is conducted under vacuum.

46. The method of claim 39 , wherein the soluble extraction product is osteoinductive.

47. The method of claim 46 , wherein the extraction medium comprises citric acid, hydrochloric acid, acetic acid, lactic acid or malic acid.

48. The method of claim 40 , further comprising sterilizing the treated soluble extraction product.

49. The method of claim 41 , further comprising sterilizing the composition of step (d).

50. The method of claim 42 , further comprising sterilizing the composition of step (e).

51. The method of claim 40 , wherein the treating of step (c) comprises lyophilization.

52. An osteogenic surgical implant comprising

a surgical implant coated with the composition of claim 23 .

53. A method of treating a bone defect comprising

applying to a bone defect an effective amount of the composition defined in claim 25 .

54. A method of treating a bone defect comprising

applying to a bone defect an effective amount of the composition defined in claim 26 .

55. An osteogenic composition resulting from a process comprising:

(a) subjecting demineralized bone to an acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature of about room temperature to produce an insoluble extraction product and a soluble extraction product;

(b) separating the insoluble extraction product and the soluble extraction product;

(c) drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product to produce a dried soluble extraction product; and

(d) combining the dried soluble extraction product of step (c) with demineralized bone particles.

56. A method for preparing an osteogenic composition comprising:

(a) subjecting demineralized bone to an acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature of about room temperature to produce an insoluble extraction product and a soluble extraction product;

(b) separating the insoluble extraction product and the soluble extraction product;

(c) drying the soluble extraction product to remove all or substantially all of the moisture in the soluble extraction product to produce a dried soluble extraction product; and

(d) combining the dried soluble extraction product of step (c) with demineralized bone particles.

57. A composition comprising a separated soluble extraction product derived from demineralized bone contacted with acidic extraction medium at a pH of between about 0.5 and about 5.5 at an extraction temperature of about room temperature.

58. The composition of claim 1 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

59. The composition of claim 1 , wherein the extraction medium comprises 2.0M to 3.0 M citric acid.

60. The composition of claim 1 , wherein the extraction medium comprises 3.0M citric acid.

61. The composition of claim 11 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

62. The composition of claim 11 , wherein the extraction medium comprises 2.0M to 3.0M citric acid.

63. The composition of claim 11 , wherein the extraction medium comprises 3.0M citric acid.

64. The composition of claim 23 , wherein the soluble extraction product is osteoinductive.

65. The composition of claim 23 , wherein the extraction medium comprises citric acid, hydrochloric acid, acetic acid, lactic acid or malic acid.

66. The composition of claim 23 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

67. The composition of claim 23 , wherein the extraction medium comprises 2.0M to 3.0M citric acid.

68. The composition of claim 23 , wherein the extraction medium comprises 3.0M citric acid.

69. The composition of claim 39 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

70. The composition of claim 39 , wherein the extraction medium comprises 2.0M to 3.0M citric acid.

71. The composition of claim 39 , wherein the extraction medium comprises 3.0M citric acid.

72. The composition of claim 55 , wherein the soluble extraction product is osteoinductive.

73. The composition of claim 55 , wherein the extraction medium comprises citric acid, hydrochloric acid, acetic acid, lactic acid or malic acid.

74. The composition of claim 55 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

75. The composition of claim 55 , wherein the extraction medium comprises 2.0M to 3.0M citric acid.

76. The composition of claim 55 , wherein the extraction medium comprises 3.0M citric acid.

77. The composition of claim 56 , wherein the soluble extraction product is osteoinductive.

78. The composition of claim 56 , wherein the extraction medium comprises citric acid, hydrochloric acid, acetic acid, lactic acid or malic acid.

79. The composition of claim 56 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

80. The composition of claim 56 , wherein the extraction medium comprises 2.0M to 3.0M citric acid.

81. The composition of claim 56 , wherein the extraction medium comprises 3.0M citric acid.

82. The composition of claim 57 , wherein the soluble extraction product is osteoinductive.

83. The composition of claim 57 , wherein the extraction medium comprises citric acid, hydrochloric acid, acetic acid, lactic acid or malic acid.

84. The composition of claim 57 , wherein the extraction medium comprises 1.0M to 10.0 M citric acid.

85. The composition of claim 57 , wherein the extraction medium comprises 2.0M to 3.0M citric acid.

86. The composition of claim 57 , wherein the extraction medium comprises 3.0M citric acid.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Nov 12, 2024
From: BLUE TORCH FINANCE LLC
To: ISOTIS ORTHOBIOLOGICS, INC.; ORTHOFIX US, LLC; SEASPINE, INC.; SEASPINE ORTHOPEDICS CORPORATION; SPINAL KINETICS LLC; THEKEN SPINE, LLC
Reel/Frame 069358/0110 →
RELEASE OF SECURITY INTEREST Recorded Nov 7, 2024
From: JPMORGAN CHASE BANK, N.A.
To: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
Reel/Frame 069323/0561 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ISOTIS ORTHOBIOLOGICS, INC.
To: BLUE TORCH FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 066258/0555 →
SECURITY INTEREST Recorded Feb 21, 2023
From: SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE ASSISTANT
Reel/Frame 062819/0650 →
RELEASE OF SECURITY INTEREST Recorded Jan 9, 2023
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
Reel/Frame 062336/0593 →
SECOND AMENDMENT TO PATENT SECURITY AGREEMENT Recorded Jul 18, 2022
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC; SEASPINE ORTHOPEDICS INTERMEDIATECO, INC.; 7D SURGICAL USA INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 060715/0395 →
SECURITY INTEREST Recorded Dec 28, 2015
From: SEASPINE HOLDINGS CORPORATION; SEASPINE ORTHOPEDICS CORPORATION; SEASPINE, INC.; ISOTIS, INC.; SEASPINE SALES LLC; ISOTIS ORTHOBIOLOGICS, INC.; THEKEN SPINE, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 037393/0895 →